Older People With Type 2 Diabetes See Growing Cancer Burden
Older people with type 2 diabetes faced a higher burden of cancer mortality in recent years, according to a U.K. study. In a cohort of over 137,000 individuals with type 2 diabetes, all-cause mortality rates dropped among all age groups from 1998-2018, reported Suping Ling, PhD, of the University of Leicester in England, and colleagues. […]
Type 2 Diabetes Patients Can Also Benefit From Fully Closed-Loop System
Even patients with type 2 diabetes can benefit from using a fully closed-loop insulin delivery system, also known as an artificial pancreas, according to an open-label crossover trial. In the randomized trial of 28 adults, patients spent a greater average proportion of time in target glucose range — 70 to 180 mg/dL (3.9 to 10.0 […]
Microprotein increases appetite in mice: Scientists discovered more than 3,800 small proteins involved in metabolism and found that one microprotein, Gm8773, increases feeding activity in mice–providing a potential new approach to encourage weight gain in people with cancer and other diseases
Obesity and metabolic diseases, such as diabetes, are extremely common in the United States. Tiny proteins called microproteins have long been overlooked in research, but new evidence demonstrates that they have an important role in metabolism. Salk scientists have discovered that both brown and white fat is filled with thousands of previously unknown microproteins, and […]
Metformin Protective Against Joint Replacement in Type 2 Diabetes
Among people with type 2 diabetes, use of metformin might help to stave off total joint replacement, a population-based cohort study showed. Among over 40,000 patients, daily metformin was associated with a 30% lower risk for total knee and hip replacement compared with no metformin (adjusted HR 0.70, 95% CI 0.60-0.81) over a median follow-up […]
Wyoming Diabetes Prevention Efforts Focus on Prediabetes – Wyoming Department of Health
Wyoming Diabetes Prevention Efforts Focus on Prediabetes December 1, 2022 Because of the strong link between prediabetes and Type 2 diabetes, the Wyoming Department of Health (WDH) is encouraging people to learn more about their personal prediabetes risk through a simple screening option. Amber Nolte, Chronic Disease Prevention Program manager with WDH, estimated one in […]
Intermittent fasting may reverse type 2 diabetes, according to study: Study finds people with diabetes who fast intermittently may no longer need medication
After an intermittent fasting diet intervention, patients achieved complete diabetes remission, defined as an HbA1c (average blood sugar) level of less than 6.5% at least one year after stopping diabetes medication, according to a new study published in the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism. Intermittent fasting diets have become popular in recent […]
Type 2 Diabetes Cases Rising in Young Adults Globally
The global burden of type 2 diabetes among young people significantly rose since 1990, researchers reported. Drawing on data from 204 countries and territories, the age-standardized incidence of type 2 diabetes from 1990 to 2019 increased from 117.22 to 183.36 per 100,000, Fan Wang, PhD, of Harbin Medical University in China, and colleagues said in […]
At risk for diabetes? Cut the carbs, says new study
While low-carb diets are often recommended for those being treated for diabetes, little evidence exists on whether eating fewer carbs can impact the blood sugar of those with diabetes or prediabetes who aren’t treated by medications. Now, according to new research from Tulane University, a low-carb diet can help those with unmedicated diabetes — and […]
Intermittently Scanned CGM Reduced HbA1c in Type 1 Diabetes
Adults with uncontrolled type 1 diabetes saw a benefit when using intermittently scanned continuous glucose monitoring (CGM), the randomized FLASH-UK Trial showed. Compared with traditional fingerstick testing, use of a intermittently scanned CGM, which offers optional alarms for high and low blood glucose levels set by the user, reduced HbA1c levels, with an adjusted mean […]
SGLT2 Inhibitors, GLP-1 RAs Not Cost-Effective as First-Line T2D Agents
Although using newer classes of diabetes drugs as first-line therapy can boost life expectancy, this strategy can be quite pricey, according to a cost-effectiveness study. Compared with traditional first-line metformin, first-line SGLT2 inhibitors cost $43,000 more over a lifetime, and first-line GLP-1 receptor agonists cost $49,000 more, reported Neda Laiteerapong, MD, MS, of the University […]